Holen Sie sich die Stockscreener-App
2.62
0.00%
0.00
Schlusskurs vom Vortag:
$2.62
Offen:
$2.5511
24-Stunden-Volumen:
183
Relative Volume:
0.00
Marktkapitalisierung:
$6.03M
Einnahmen:
$9.26M
Nettoeinkommen (Verlust:
$-941.60K
KGV:
-36.39
EPS:
-0.072
Netto-Cashflow:
$-2.65M
1W Leistung:
+4.80%
1M Leistung:
+31.66%
6M Leistung:
-48.02%
1J Leistung:
-23.30%
1-Tages-Spanne:
$2.5511
$2.5511
1-Wochen-Bereich:
$2.475
$2.73
52-Wochen-Spanne:
$1.92
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Firmenname
Bionexus Gene Lab Corp
Sektor
Branche
Telefon
1-307-241-6898
Adresse
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
2.1602 | 2.87B | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
7.67 | 465.95M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.24 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
3.77 | 350.59M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
45.59 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Aktie (BGLC) Neueste Nachrichten
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman - Bitget
Chemrex board cut to two as BioNexus weighs new growth options - Stock Titan
Financial Comparison: Beauty Health (NASDAQ:SKIN) vs. BioNexus Gene Lab (NASDAQ:BGLC) - Defense World
BioNexus Gene Lab (NASDAQ:BGLC) Stock Price Up 1.7% – Still a Buy? - Defense World
Sentiment Review: Does T Stamp Inc stock reflect fundamentalsJuly 2025 Sentiment & Smart Allocation Stock Tips - baoquankhu1.vn
Will BioNexus Gene Lab Corp. stock recover after earningsInsider Selling & Smart Swing Trading Alerts - mfd.ru
BGLC Should I Buy - Intellectia AI
Analyst Upgrade: What is the Moat Score of BioNexus Gene Lab CorpJuly 2025 Rallies & Weekly Market Pulse Alerts - baoquankhu1.vn
12 Industrials Stocks Moving In Wednesday's Pre-Market Session - Benzinga
BioNexus Launches Regional Deployment of VitaGuard MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN's Multi-Billion Dollar Market - Finviz
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market - marketscreener.com
BioNexus Launches Regional Deployment of VitaGuard™ MRD - GlobeNewswire
Analyst Calls: Is BioNexus Gene Lab Corp a strong candidate for buy and hold2025 Price Targets & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Block Trades: Will BioNexus Gene Lab Corp outperform its industry peersJuly 2025 Outlook & Fast Entry Momentum Alerts - baoquankhu1.vn
BioNexus Gene Lab stockholders back governance and incentive plan - MSN
Whale Trades: Can BioNexus Gene Lab Corp be the next market leaderMarket Performance Summary & Entry Point Confirmation Signals - baoquankhu1.vn
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update - Defense World
Bearish Setup: Will BioNexus Gene Lab Corp outperform its industry peersJuly 2025 Summary & Consistent Return Investment Signals - baoquankhu1.vn
New Highs: Will QCR Holdings Inc stock recover after earningsDay Trade & Smart Swing Trading Alerts - baoquankhu1.vn
Why BioNexus Gene Lab Corp. stock is trending among retail tradersJuly 2025 Rallies & Precise Buy Zone Identification - Улправда
Insider Trends: Can BioNexus Gene Lab Corp. stock deliver sustainable ROEJuly 2025 Levels & Community Driven Trade Alerts - Улправда
How BioNexus Gene Lab Corp. stock reacts to job market dataJuly 2025 Intraday Action & Verified Stock Trade Ideas - Улправда
Can BioNexus Gene Lab Corp. stock deliver sustainable ROEJuly 2025 Levels & Community Driven Trade Alerts - ulpravda.ru
Why BioNexus Gene Lab Corp. stock is recommended by analystsJuly 2025 Chart Watch & AI Powered Market Entry Ideas - Улправда
Downgrade Watch: Can BioNexus Gene Lab Corp stock resist market sell offsShort Setup & Technical Pattern Alert System - moha.gov.vn
BioNexus Gene Lab Stockholders Back Governance and Incentive Plan - The Globe and Mail
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting - Investing.com Australia
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting By Investing.com - Investing.com South Africa
How supply chain issues affect BioNexus Gene Lab Corp. stockMarket Insider Reports & Capitalize On Fast Trends - bollywoodhelpline.com
BioNexus Gene Lab (NASDAQ:BGLC) Shares Down 0.2% – Should You Sell? - Defense World
BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership - MSN
BioNexus Chemrex leadership resignations prompt governance review - The Globe and Mail
Bionexus Gene Lab CorpMatthew L. Barsing appointed as chairman of Chemrex boardSEC filing - marketscreener.com
BioNexus Gene Lab Corp Evaluates CDMO Expansion - TradingView — Track All Markets
Inflation Data: Is BioNexus Gene Lab Corp. stock attractive after correctionQuarterly Portfolio Review & Daily Growth Stock Tips - DonanımHaber
What margin trends mean for BioNexus Gene Lab Corp. stockPortfolio Value Summary & Real-Time Volume Spike Alerts - DonanımHaber
Will BioNexus Gene Lab Corp. stock gain from lower inflation2025 Trade Ideas & Expert Approved Trade Ideas - DonanımHaber
Is BioNexus Gene Lab Corp. stock attractive after correction2025 Key Highlights & Growth Focused Entry Reports - DonanımHaber
Can BioNexus Gene Lab Corp. stock maintain growth trajectory2025 Market WrapUp & Stepwise Trade Execution Plans - Улправда
Bionexus Gene Lab completes investment in Fidelion Diagnostics - MSN
Analysis Recap: How BioNexus Gene Lab Corp stock valuations compare to rivalsStop Loss & Target Return Focused Stock Picks - moha.gov.vn
BioNexus Gene Lab stock soars after strategic MRD testing agreements By Investing.com - Investing.com Nigeria
Is BioNexus Gene Lab Corp. stock safe for conservative investorsWeekly Profit Summary & Stepwise Trade Execution Plans - Newser
12 Industrials Stocks Moving In Thursday's Pre-Market Session - Benzinga
Finanzdaten der Bionexus Gene Lab Corp-Aktie (BGLC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):